Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2015

Dec 3, 2015

31802_dirs_2015-12-03_2d9ec1a9-1b26-4a89-b422-073e701c4678.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2015-12-01

Reporting Person: Krell Elizabeth D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-01 Common Stock M 10000 $7.99 Acquired 17162 Direct
2015-12-02 Common Stock S 10000 $21.88 Disposed 7162 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-01 Stock Option (right to buy) $7.99 M 10000 Disposed 2016-06-21 Common Stock (10000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $21.63 to $22.01 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: These options were granted on June 21, 2006 and are exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant.